| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 362.046 | 877.548 | 1.258.586 | 2.712.403 |
| Total Income - EUR | - | - | - | - | - | - | 362.046 | 877.621 | 1.295.780 | 2.714.438 |
| Total Expenses - EUR | - | - | - | - | - | - | 167.732 | 342.763 | 645.856 | 1.619.754 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 194.313 | 534.858 | 649.924 | 1.094.684 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 191.489 | 528.926 | 585.948 | 964.317 |
| Employees | - | - | - | - | - | - | 5 | 7 | 10 | 16 |
Check the financial reports for the company - Biointegrativ S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 28.423 | 284.640 | 1.187.624 |
| Current Assets | - | - | - | - | - | - | 194.811 | 537.325 | 654.148 | 571.202 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 181.168 | 506.702 | 627.545 | 524.850 |
| Cash | - | - | - | - | - | - | 13.643 | 30.623 | 26.604 | 46.351 |
| Shareholders Funds | - | - | - | - | - | - | 191.529 | 554.103 | 673.591 | 1.193.580 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.282 | 11.646 | 268.817 | 565.246 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8696 - 8696" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biointegrativ S.r.l.